Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) after high-dose conditioning regimens imposes prohibitively high risks of morbidity and mortality for patients with high-risk acute myeloid leukemia (AML) who are older or have comorbid conditions. Here, we examined outcomes after nonmyelo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gyurkocza, Boglarka, Storb, Rainer, Storer, Barry E., Chauncey, Thomas R., Lange, Thoralf, Shizuru, Judith A., Langston, Amelia A., Pulsipher, Michael A., Bredeson, Christopher N., Maziarz, Richard T., Bruno, Benedetto, Petersen, Finn B., Maris, Michael B., Agura, Edward, Yeager, Andrew, Bethge, Wolfgang, Sahebi, Firoozeh, Appelbaum, Frederick R., Maloney, David G., Sandmaier, Brenda M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2010
Materias:
Original Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903320/
https://ncbi.nlm.nih.gov/pubmed/20439626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.1460
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares